Answers are grounded in this paper and cite their sources.
This review outlines the effectiveness of adrenergic drugs to manage glaucoma, suggesting potential benefits and risks.
A review of the rationale for use of adrenergic drugs in the treatment of glaucoma, and their application in research to manage wide‐angle chronic glaucoma with central nervous system stimulants. Use and possible ocular and systemic complications resulting from treatment with monoamine oxidase inhibitors and other major psychoanaleptics are considered.
No takes yet. Share an insight, caveat, or question.
James F. Koetting (1970) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: